Neogenomics Inc (NASDAQ:NEO)

4.84
Delayed Data
As of 3:59pm ET
 +0.02 / +0.41%
Today’s Change
2.98
Today|||52-Week Range
6.10
+16.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-1.2M65.0K2.0M1.1M
 
 
 
 
 
Depreciation2.1M3.8M4.4M5.6M
 
 
 
 
 
Total Other Cash Flow3.1M3.9M3.7M3.2M
 
 
 
 
 
Funds From Operations4.0M7.8M10.1M10.0M
 
 
 
 
 
Funds From/For Other Operating Expenses3.9M8.3M7.9M517.0K
 
 
 
 
 
Net Cash Flow - Operating Activities69.0K-492.0K2.2M9.5M
 
 
 
 
 
 
InvestingCapital Expenditures-897.0K-2.6M-2.0M-3.8M
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-5.8M
 
 
Net Cash Flow Investing-897.0K-3.7M-2.0M-9.6M
 
 
 
 
 
 
FinancingShort Term Borrowings456.0K4.6M-4.2M-4.3M
 
 
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-1.6M-2.2M-2.6M-3.6M
 
 
 
 
 
Net Proceeds Stock Sale3.5M511.0K9.5M36.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00500.0K0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.4M3.4M2.8M29.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash1.5M-760.0K3.0M28.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account